clenbuterol has been researched along with bucladesine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CY; Mills, SE | 2 |
| Radda, GK | 1 |
| Kemp, GJ; Odoom, JE; Radda, GK | 1 |
| Kamei, C; Kirino, Y; Mio, M | 1 |
| Migliorini, RH; Navegantes, LC; Resano, NM | 1 |
| Kettelhut, IC; Machado, CR; Migliorini, RH; Navegantes, LC; Resano, NM | 1 |
| Doornbos, RP; Rodenburg, RJ; van der Greef, J; Verhoeckx, KC; Witkamp, RF | 1 |
8 other study(ies) available for clenbuterol and bucladesine
| Article | Year |
|---|---|
Sensitivity of lipolysis and lipogenesis to dibutyryl-cAMP and beta-adrenergic agonists in swine adipocytes in vitro.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic beta-Agonists; Animals; Bucladesine; Cells, Cultured; Clenbuterol; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Fatty Acids; Insulin; Lipolysis; Male; Phenethylamines; Swine; Theophylline | 1990 |
Decreased insulin binding to porcine adipocytes in vitro by beta-adrenergic agonists.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic beta-Agonists; Animals; Bucladesine; Cells, Cultured; Clenbuterol; Epinephrine; Insulin; Male; Phenethylamines; Propranolol; Receptor, Insulin; Swine; Theophylline | 1990 |
Control of energy metabolism during muscle contraction.
Topics: Animals; Biological Transport; Bucladesine; Cells, Cultured; Clenbuterol; Creatine; Energy Metabolism; Humans; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Muscle Contraction; Muscles; Norepinephrine; Phosphates; Physical Exertion; Rats | 1996 |
The regulation of total creatine content in a myoblast cell line.
Topics: Animals; Atenolol; Bucladesine; Butoxamine; Cell Line; Clenbuterol; Creatine; Energy Metabolism; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Labetalol; Methoxamine; Mice; Muscle, Skeletal; Norepinephrine; Phentolamine; Propranolol; Sodium; Triiodothyronine | 1996 |
Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bucladesine; Calcimycin; Carbazoles; Cells, Cultured; Clenbuterol; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Eosinophil Peroxidase; Eosinophils; Fenoterol; Guinea Pigs; Indoles; Intracellular Fluid; Ionophores; Male; Peroxidases; Phosphodiesterase Inhibitors; Pyrroles; Receptors, Adrenergic, beta-2; Theophylline; Time Factors | 2000 |
Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP.
Topics: Adrenal Medulla; Adrenergic beta-2 Receptor Agonists; Animals; Bucladesine; Calcium; Catecholamines; Clenbuterol; Cyclic AMP; Endopeptidases; Epinephrine; Lysosomes; Male; Muscle Proteins; Muscle, Skeletal; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2 | 2001 |
Beta2-agonists and cAMP inhibit protein degradation in isolated chick (Gallus domesticus) skeletal muscle.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Chickens; Clenbuterol; Epinephrine; Kinetics; Muscle Proteins; Muscle, Skeletal; Propanolamines; Receptors, Adrenergic, beta-2 | 2003 |
Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages.
Topics: Adrenergic beta-Agonists; Bucladesine; Chemokine CXCL6; Chemokines, CXC; Clenbuterol; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages; Oncostatin M; Trimethylsilyl Compounds; U937 Cells; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |